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Abstract 
Background and Purpose: Individuals with Huntington’s disease (HD), a rare neurological 
disease, experience impairments in mobility and cognition throughout their disease course. The 
Medical Research Council Framework (MRC) provides a framework that can be applied to the 
development and evaluation of complex interventions, such as those provided by physical 
therapists.  Treatment-based classifications, based on expert consensus and available literature 
are helpful in guiding physical therapy management across the stages of HD and contributing to 
the development and further evaluation of well-defined complex interventions in this highly 
variable and complex neurodegenerative disease.  The purpose of this case series was to illustrate 
the use of these classifications in the management of two individuals with late-stage HD. 
Case Description: Two females, ages 40 and 55, with late-stage HD participated in this study. 
Both experienced progressive declines in ambulatory function and balance as well as falls or fear 
of falling. Both individuals received daily care in the home for ADLs. 
Intervention: Physical Therapy Treatment based classifications for HD guided the interventions 
and outcomes. Eight weeks of in-home balance training, strength training, task-specific practice 
of functional activities including transfers and walking tasks, and family/carer education was 
provided.  
Outcomes: Both individuals demonstrated improvements that met or exceeded the established 
minimal detectible change (MDC) values for gait speed and Timed Up and Go performance. 
Both also demonstrated improvements on Berg Balance Scale and Physical Performance Test 
performance, with one of the two exceeding the established MDCs for both tests. Reductions in 
fall risk were evident in both cases. 
Discussion: These cases provide proof-of-principle to support usage of Treatment Based 
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Classifications for physical therapy management for individuals with HD. Traditional 
classification of early-, mid-, and late-stage disease progression may not reflect patients’ true 
capabilities; those with late-stage HD may be as responsive to interventions as those at an earlier 
disease stage. 
Keywords: Huntington’s disease, gait, balance, falls, mobility; case series  
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Introduction 
 Huntington’s disease (HD) is a progressive neurodegenerative disorder resulting in 
cognitive, motor and psychosocial dysfunction. Motor impairments lead to activity limitations 
related to walking, transferring and performing activities of daily living (ADLs). In addition to 
increased gait variability and slow walking,1 individuals with HD experience deficits in 
anticipatory postural adjustments, postural responses, gait and static balance under changing 
sensory conditions2 and while performing motor skills integral to ADLs.3  As a result, these 
individuals are at increased risk for falls, and the sequelae resulting from subsequent mobility 
restrictions. More than 50% of individuals with HD are recurrent fallers, experiencing two or 
more falls per year.4,5 Not surprisingly, recurrent HD fallers walk more slowly, perform more 
poorly on balance testing and are less physically active when compared to non-fallers with HD.4 
Motor impairments and increased fall risk contribute to loss of independence, social isolation, 
reduced self-esteem and loss of family role in individuals with HD. 
Studies in HD animal models suggest that exercise improves motor function,6 delays the 
progression of cognitive dysfunction,6 and provides neuroprotection in the form of delayed 
disease onset.7,8 In recent years, several small scale feasibility studies have investigated the 
effects of exercise and physical therapy in HD9–15 with improvements observed in dynamic 
balance,9,1010,11 gait speed, function and level of physical activity,10,14 fitness,13 cognitive 
function,16 neuroplasticity,16 and self-reported quality of life measures.11,12 These studies 
included early to mid-stage participants, and although they demonstrated proof-of-concept, were 
underpowered to establish efficacy. Full scale exercise trials are difficult to achieve in rare 
diseases, and are as yet outstanding for HD. To date, there are no reports of exercise 
interventions in mid to late-stage HD.  
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Response to exercise training and physical therapy in HD is variable; this may be due to a 
host of disease-related (i.e., disease variability, genetic predisposition, psychosocial) and 
environmental (i.e., carer support to gender, beliefs, socioeconomic status) factors. Another 
potential factor is the classification, or staging, system used to categorize patients is The United 
Huntington’s Disease Rating Scale (UHDRS) Total Motor Score (TMS)17. UHDRS-TMS is a 
subjective evaluation of motor impairments, encompassing bradykinesia, chorea, dystonia, motor 
impersistence, balance and gait. The Total Functional Capacity (TFC) Scale is a more global 
scale of functional status, encompassing occupation, finances, domestic chores, ADLs and care 
level. Scores on the TFC range from 0-13, and patients are typically categorized as early stage 
(10-13), mid stage (7-9), and late stage (0-6).  Because of the range of items and scoring criteria, 
individuals with the similar overall UHDRS-TMS or TFC scores can present quite differently. 
Furthermore, the TFC is not related specifically to movement and is limited to a categorical 
assessment of levels of assistance. Thus, a stratification system to better understand clinical 
subtypes and guide physical therapy intervention is needed. 
An enduring question in physical therapy (PT) practice is whether, and to what extent, the 
interventions that form part of standard practice are effective and efficient. Lack of clear 
definitions and categorization of intervention components, as well as inconsistency in the 
terminology applied in published trials, limits not only our understanding of the active 
ingredients of interventions but also the replication thereof. Furthermore, knowledge translation 
is difficult and this limits opportunities for research to inform clinical practice and  
vice versa. The Medical Research Council (MRC) of the United Kingdom provides a framework 
for developing and evaluating complex interventions18,19 as well as incorporating process 
evaluations to better understand context-driven mediators of outcome20. Intervention 
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development begins with identifying evidence, theoretical component, and modeling process and 
outcomes (see Figure 1).  Where appropriate, this should extend from pre-clinical studies to 
qualitative inquiry that iteratively inform subsequent feasibility and acceptability studies.  
Efficacy and implementation only occurs after a comprehensive process of development and 
feasibility testing. 
<Figure 1 here> 
In totality, the guidance calls for transparent development of theoretically driven interventions, 
the use of qualitative methods to support intervention development and evaluation, and 
monitoring of intervention delivery. Importantly, there should be flexibility in the stages of 
development such that piloting, evaluation and implementation develops based on emerging 
evidence.  
In an effort to facilitate the development of theoretically driven interventions in HD, our 
group has developed Physical Therapy Guidelines for HD that utilize Treatment Based 
Classifications (TBCs)21,22 (Table 1). These TBCs define the primary activity deficits and 
underlying impairments of individuals with HD, group individuals by their response to 
interventions, and provide recommended interventions and outcome measures to monitor 
longitudinal change. In theory, TBCs23,24 provide a useful scale to guide treatment decisions and 
determine rehabilitation goals following physical therapy evaluation of specific symptoms and 
activity deficits and determination of the classification that best fits their client’s individual 
needs. The TBCs were developed by expert consensus and guided by available literature, with 
the purpose of guiding clinical decision-making. An important goal of the TBCs was to further 
validate the classifications utilizing case studies and clinical trials. Therefore, the objective of 
this case series is to describe the physical therapy intervention and outcomes for two individuals 
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with late-stage HD, and to apply their intervention to the TBCs developed for HD. With a 
paucity of exercise interventions including individuals with late-stage HD, single case studies 
may provide useful information and proof-of-principle of the beneficial components of physical 
therapy interventions.  
<Table 1 here> 
 
Case Description 
Participants  
Both participants were in the late-stage of HD, as defined by TFC scores (Table 2) and 
receiving regular clinical care at the Cardiff Huntington’s disease Research and Management 
Clinic. Participants were consented under parent studies; Case 1 was assigned to the control arm 
of the TRAIN-HD study (Ethics: NHS REC 12/WA/0151).12 The control arm received a 
modified version of the intervention after completion of the study, but was excluded from the 
analysis as she was unable to complete the minimum dataset. For those in the control group, 
participants were seen 1-2x/week, and received a modified version of the protocol, which 
allowed for more independent decision-making by the therapist. Case 2 was assigned to the 
intervention group of Move to Exercise (Ethics: 09/WSE02/24) and received the intervention as 
defined by the study protocol.10  
Case 1 (AA) 
History 
  AA was a 40-year-old female diagnosed with HD at age 34. At evaluation, she was 
housebound, required assistance with all functional activities, did not work, and lived with her 
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husband and 6-year-old daughter in a two-story home. She had a carer available for 15 hours 
daily. AA’s medical history was unremarkable. Her medications are listed in Table 2.  
 Over the past several years, AA experienced a progression of symptoms, and was 
referred to physical therapy to address her primary activity limitations of poor balance, difficulty 
with ambulation, and transfers complicated by reduced aerobic capacity and poor motivation. 
<Table 2 here> 
 Exam  
 At evaluation, AA presented with moderate to severe rigidity throughout her trunk, upper 
and lower extremities. AA was able to maintain unsupported static standing balance for a short 
period but required assistance of one person during additional movements or with perturbations. 
Her strength was 4/5 throughout and gait was notable for a wide base of support, dystonia in 
bilateral feet (inversion and mild plantarflexion), bradykinesia, and akinesia with initiation of 
movement slow and effortful. AA was able to ambulate with assistance of one person over three 
meters but used a wheelchair for community mobility.   
AA’s carers performed all personal and domestic ADLs. AA was unable to roll or move 
from lying to sitting or sitting to lying. She required moderate assistance to rise from a chair. 
Prior to this evaluation, she had been labeled a “high handling risk” by the Manual Handling 
Risk Assessment required by the UK Health and Safety at Work Act Regulations (1974). As a 
result, electronic adaptations and aids were utilized by her carers, and her mobility was limited to 
short indoor distances with assistance. The therapist also noted apathy and lack of engagement in 
daily activities. Mobility was assessed as described in the Outcomes section below and in 
Figures 2 and 3. 
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Case 2 (BB) 
History 
BB was a 55-year-old female diagnosed with HD at age 50. At evaluation, she required 
assistance to manage her finances, home maintenance, and food preparation. BB did not work, 
lived alone in a first-floor apartment, and had a carer 4 days per week to assist with ADL 
activities. Her past medical history is notable for depression, hyperthyroidism and hypertension. 
Her medications are listed in Table 2. 
Over the past five years, BB experienced a gradual progression of symptoms, and was 
referred to physical therapy by her neurologist. Her primary activity limitations were poor 
balance and difficulty walking independently. BB’s primary concern was fear of falling 
following a previous fall that resulted in multiple injuries and hospitalization. 
Exam  
 BB was independent with dressing and bathing, but used a walker for ambulation inside 
the home and a wheelchair for community mobility. Her mobility was assessed as described in 
the Outcomes section below and in Figures 2 and 3.  
 
Outcome Measures 
Measures of Activities 
Physical Performance Test. The Physical Performance Test (PPT)25 requires individuals to 
perform nine tasks that mimic basic to standard activities of daily living. Each item is rated on a 
4-point scale for a maximum score of 36. The PPT is an appropriate measure of function in 
individuals with HD26 that demonstrates excellent test-retest reliability in individuals with 
manifest (i.e., motor symptoms are present) HD and has an MDC of 5.27  
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Walking Speed. During the 10-meter walk test (10MWT),28 participants ambulate at their self-
selected comfortable pace across 14 meters; 2 meters to allow for acceleration, 10 meters where 
their time to walk is measured, and 2 meters to allow for deceleration. The time to complete the 
10 meters is recorded and gait speed (distance/time) is calculated. The 10MWT gait speed 
measure has excellent test-retest reliability and an established MDC of 0.3 m/s for individuals 
with HD.27 
Timed Up and Go. The Timed Up and Go (TUG)29 requires participants to stand from a chair, 
walk 3 meters, turn, and return to a seated position in the chair. The participant performs one 
practice and one test trial, and the time is complete the task is recorded. The TUG is a good 
disease-specific measure of mobility in HD26 with excellent test-retest reliability and an 
established MDC of 2.98 seconds in individuals with HD.27 Individuals with HD are at increased 
risk of falls if TUG >14 seconds.4 
Six-Minute Walk Test. The 6-minute walk test (6MWT)30 was collected in Case 1 only as a 
measure of walking endurance. During the 6MWT, an individual ambulates for 6 minutes and 
the total distance in meters is recorded. The 6MWT has good-excellent test-retest reliability and 
an established MDC of 86.57 meters in individuals with HD.27 
Measures of Impairments in Body Function 
Berg Balance Scale. The Berg Balance Scale (BBS)31 is a 14-item scale that assesses static 
balance performance. Quality of performance on each item is scored using a 4-point scale, for a 
maximum score of 56. The BBS is a good disease-specific mobility measure in HD26 that has 
excellent test-retest reliability in individuals with HD and MDC of 5 for individuals with 
manifest HD.27 Individuals with HD are at increased risk of falls if BBS<40.4  
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Four Square Step Test. The Four Square Step Test (FSST)32 was collected in Case 2 only as a 
measure of dynamic standing balance. The FSST requires an individual to step over four canes, 
placed in a cross configuration on the floor, in a specific sequence (forward, right, backward, 
left), and then repeat this sequence in the reverse order. The time to complete this task is 
recorded as the final score. The FSST has good test-retest reliability and an established MDC of 
15.27 seconds in individuals with manifest HD.27  
Measures of Quality of Life 
Short Form-36. The Short Form-36 (SF-36)33 was collected in Case 2 only to assess health-
related quality of life in both the mental and physical domains. The SF-36 is reliable and valid 
for individuals with HD and their carers.34  
 
Intervention 
Despite enrollment in parent studies, both cases met criteria for classification in TBC C: 
Mobility, Balance and Falls Risk, in the HD Clinical Guidelines, including interventions such as  
balance training, strength training, task-specific practice of functional activities including 
transfers and walking tasks, and family/carer education (see Table 1, and also Table C from 
http://www.futuremedicine.com/doi/pdf/10.2217/nmt.11.86).22 
Case 1. 
 AA received one-on-one physical therapy for 8 weeks, delivered 1x/week for 1 hour. The 
program consisted of home-based physical therapy focusing on walking, balance and transfer 
practice. The therapist also educated and trained the family and carers. The intervention focused 
on three main concepts: a) mobility and skills training; b) motivation and goal-setting; and c) 
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opportunity and enablement. Between physical therapy visits, the lead carer conducted 
independent sessions for 1 hour/day over the 8-week intervention. 
 Mobility training consisted of task-specific balance and strength training in functional 
transfers, gait, reaching, bed mobility, stair-climbing and turning. To progress the difficulty, gait 
was performed both indoors and outdoors, car transfers were practiced, turning was performed in 
tight spaces, and the time spent on each activity was increased to build endurance. An emphasis 
was placed on simple verbal instructions and positive reinforcement. 
 The motivation component of the intervention consisted of setting achievable, 
meaningful goals to allow AA to demonstrate her abilities and build confidence. An ultimate 
goal of a family holiday motivated AA to participate in functional tasks and outdoor ambulation. 
 The opportunity component of the intervention focused on enabling AA to participate in 
her daily life, family life, and physical activities.  
Case 2. 
 The intervention for BB took place within BB’s home also over a period of 8 weeks, and 
was focused on the following concepts: a) gait and postural control; b) functional mobility; c) 
health-related quality of life. BB was instructed to perform exercises at home 3x/week using a 
purpose-developed exercise DVD35 (please see 
https://www.youtube.com/channel/UCH7_ed2__mkzXNWPZqVIosw for videos). Briefly, the 
DVD consisted of 5 sections: a) warm-up and flexibility; b-d) strength and balance exercises 
tailored specifically for individuals with HD; e) cool down and relaxation. The balance exercises 
were divided into two sections. The first section focused on practicing narrowed and altered 
functional base of support exercises. The easiest of the exercises required the participant to 
maintain balance while the heels and toes of the feet were touching. To progress the difficulty, 
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these movements were performed with eyes closed, standing on one leg, tandem stance, or 
during forward and side lunges. Level of support was also progressed from holding onto a 
table/chair to using support only as needed. The second section of balance exercise focused on 
performance of task-specific activities that required alterations of dynamic balance, such as 
transfers from sitting to standing, turning, and stepping up onto stairs. To progress the difficulty, 
the number of repetitions was increased and the number of rest breaks was decreased.  
 During an initial home visit, the therapist taught each exercise to the participant and 
instructed BB on how to progress the exercises. The therapist also discussed the benefits and 
precautions for each exercise.  All instruction took place in the presence of a carer, who agreed 
to assist BB as needed. In addition to performing the DVD exercises, BB also began a 30-minute 
gradual progressive walking program, by walking 1x/week on level ground around her home and 
neighborhood. She was instructed to walk at her self-selected comfortable pace and to take rest 
breaks as needed. She was encouraged to progress her walk by increasing the time walked until 
she reached 30 minutes. BB was asked to keep a record of her daily exercise program in an 
exercise diary. 
 The therapist called BB weekly to monitor her progress and discuss any issues.  
 
Outcomes 
Case 1- AA. 
 AA demonstrated marked improvements in function following 8 weeks of physical 
therapy intervention. AA’s performance on the PPT improved from 4 to 16; her BBS 
performance improved from 22 to 45 and her TUG performance improved from 47.2s to 33.3s 
following training.  Similarly, gait speed and endurance also improved; at baseline AA was not 
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walking, but following training, she ambulated at 1.18m/s and walked 297.4 meters during the 
6MWT (Figures 2-3). 
 AA’s carer was actively involved in the intervention, advocating on her behalf and 
encouraging AA to engage in training on days when the physical therapist was not present. 
Qualitatively, AA’s carer noted that although she still required close supervision and occasional 
assistance: 
 “She does the weekly shopping herself, she goes out, she collects her prescriptions, 
 everything that she needs that now has made her become a wife and mother…again.   
Since she’s been doing exercises, speech has improved as well.” 
Case 2-BB. 
 BB also demonstrated improvements in function following 8 weeks of physical therapy 
intervention. BB’s performance on the PPT improved from 13 to 15; her BBS performance 
improved from 45 to 47, and her TUG performance improved from 22.8s to 13.9s following 
training. She also demonstrated marked improvements in gait speed, ambulating at 0.39m/s prior 
to training and 0.72 m/s post-training. Additionally, she completed the FSST more quickly 
following training (12.6s pre; 11.9s post) and reported improvements on the physical functioning 
subscale of the SF-36 with a rise from 20 to 75 (Figures 2-3). 
 BB’s carer was actively involved in supporting the walking program, where her 
adherence was excellent, and went above the suggested amount of 30 minutes per week, walking 
3 times per week for 30-40 minutes total as part of shopping trips with her carer. Conversely, BB 
did not experience as much support from her carer in completing the exercises shown in the 
DVD, and her adherence rate with the exercise DVD was 2/24 (8.3%). Qualitatively, BB’s carer 
reported: 
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“There is a big improvement from the first time I saw her [two months ago], she is no 
 longer using the wheelchair. She walked from the car park to [the laboratory] today and 
  I would say that is a big improvement.”  
<Figures 2 & 3 here> 
Discussion 
The purpose of this case series was to demonstrate the use of TBCs to guide physical 
therapy treatment planning for two individuals with HD. Both individuals presented with 
primary activity limitations in mobility, balance, and falls risk (TBC C; Table 1) and 
demonstrated improvements in function following 8-weeks of physical therapy targeting gait, 
balance and fall risk reduction. Both AA and BB met the MDC values established for late-stage 
HD for gait speed and TUG, with increases in gait speed of 1.18m/s and 0.33 m/s, respectively 
and reductions in time to complete the TUG of 13.9 seconds and 8.9 seconds, respectively 
(Figure 2A-B). While BB demonstrated improvements on the BBS and PPT, only AA exceeded 
the established MDCs for late-stage HD with improvements of 23 points and 12 points, 
respectively (Figure 2C-D). Furthermore, both AA and BB experienced changes in function that 
indicate a reduced fall risk. BBS scores <40 indicate increased fall risk for individuals with HD;4 
following training, AA moved from a BBS score of 22 to 45, marking a change in fall status 
from high risk to lower risk. Similarly, individuals with a TUG score of >14 seconds are at 
higher risk for falls;4 following training, BB moved from a TUG of 22.8s to 13.9s, demonstrating 
a shift to lower fall risk. These improvements are particularly notable given that both individuals 
were the later stage of HD. 
 Within the guidelines of TBC C, the general aims of physical therapy are to: a) improve 
mobility status by increasing independence, gait speed and distance walked; b) reduce risk of 
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falls or actual falls; c) maintain independent transfers and walking; and d) reduce fear of 
falling.17 Although AA and BB both demonstrated improvements in gait, balance and function 
following 8 weeks of task-specific training, one notable difference in these cases was the 
involvement of the primary carer.  While AA’s carer was involved in all aspects of the 
intervention, BB’s carer actively supported only the walking program. Their adherence results 
support prior work stating that individuals with HD experience more success with exercise when 
their caregiver is actively involved in the intervention35 and highlight the importance of carer 
support and encouragement for task-specific practice (i.e., walking). 
At initial development, we anticipated that the TBCs would have a relationship with 
disease stage. The TBCs had sub-categories related to premanifest (TFC 13; no clinical signs of 
HD), early (TFC 10-13), middle (TFC 7-9) and late stages (TFC 0-6).  Thus, our original paper 
introducing the TBCs suggested that TBC C was applicable to individuals in early-mid stage 
HD.22 However, as this case series shows, individuals with late-stage disease can still be 
functional and respond to similar interventions as those in earlier disease stages. This case series 
extends the literature to demonstrate that later-stage clients with HD may benefit from physical 
therapy services under TBC C and should be referred to physical therapy when (or before) they 
experience declines. These cases provide proof-of-principle to support the use of TBCs to guide 
physical therapy management for individuals with HD. Although the TBCs require further 
validation across disease stages, the clear guidelines within each classification have the potential 
to address two key barriers identified by therapists treating individuals with HD: insufficient use 
of routine physical therapy-related outcome measures at different stages of HD36 and clearer 
reporting of intervention protocols so as to generate a better understanding of the impact of 
exercise and physical therapies on the symptoms of HD.37 Given the changing nature of HD and 
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the variability associated with functional deficits, TBCs have the potential to inform treatment 
planning, intervention development and subsequent evaluation in line with the MRC framework 
for complex interventions.  
Limitations  
Despite the favorable outcomes reported, the case series design limits us from drawing 
conclusions about the benefit of physical therapy for all individuals with late-stage HD. We 
acknowledge that some of the benefits may be from social contact with the physical therapists, 
but this effect was not directly measured. Prospective recordings of falls following the 
interventions were not obtained, so it is unknown if these task-specific interventions influenced 
future fall risk. TBC C recommends interdisciplinary consultations, including occupational 
therapy, nutrition, and speech therapy, which were not utilized in these studies and may have 
further improved more global outcomes in these participants. Additionally, these cases 
demonstrate the implementation of outcomes and interventions with regard to only one of the 
TBCs; future work should not only validate the TBCs, but examine their utility across disability 
levels and with regard to current evidence-based literature.  
 
Summary 
 This study provides proof-of-principle that physical therapy for mobility, balance, and 
fall risk is feasible and confers benefit for some individuals with late-stage HD. Larger studies 
with a control group are necessary to confirm these outcomes, and future work should examine 
the validity of the TBCs to inform physical therapy management of individuals with HD.  
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Table 1. Treatment Based Classifications21,22 
Classification Description 
A. Exercise capacity and performance 
Absence of motor impairment or specific limitations in functional activities; 
potential for cognitive and/or behavioral issues 
B. Planning and sequencing of tasks (including 
bradykinesia) 
Presence of apraxia or impaired motor planning; slowness of movement and/or 
altered force generation capacity resulting in difficulty and slowness in 
performing functional activities 
C. Mobility, balance and falls risk 
Ambulatory for community and/or household distances; impairments in balance, 
strength, or fatigue resulting in mobility limitations and increased falls risk 
D. Secondary adaptive changes and deconditioning 
Musculoskeletal and/or respiratory changes resulting in physical deconditioning, 
and subsequent decreased participation in daily living activities, or social/work 
environments 
E. Abnormal posturing (seating and bed positioning) 
Altered alignment due to adaptive changes, involuntary movement, muscle 
weakness and incoordination resulting in limitations in functional activities in 
sitting 
F. Respiratory dysfunction 
Impaired respiratory function and capacity; limited endurance, impaired airway 
clearance resulting in restrictions in functional activities and risk for infection 
22 
 
G. Palliative Care 
Active and passive range of motion limitations and poor active movement 
control resulting in inability to ambulate; dependent for most activities of daily 
living; difficulty maintaining upright sitting position 
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Table 2. Case Characteristics at Baseline 
 
  Case 1-AA Case 2-BB 
Age (yrs) 40 55 
Gender Female Female 
Symptom Duration (yrs) 6 5 
UHDRS-TMS 74 Not assessed 
TFC 2 5 
Medications (indication) 
Vesicare (overactive bladder) Carbimazole (hyperthyroid) 
Lansoprazole (heartburn) Paroxetine (depression) 
Clonazepam (involuntary 
movements) Ramapril (hypertension) 
Sertraline (depression) Propranolol (hypertension) 
Full UHDRS-TMS was not assessed for Case 2. Total Functional Capacity (TFC); Total Motor Score (TMS); United Huntington’s 
Disease Rating Scale (UHDRS). 
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Figure 1: Medical Research Council (MRC) framework for Developing and Evaluating Complex 
interventions (Adapted by permission from BMJ Publishing Group Limited, license number 
3912151415579). 
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Figure 2. Both individuals with late-stage HD experienced improvements in A. gait speed; B. 
Timed Up and Go performance; C. Berg Balance Scale performance; and D. Physical 
Performance Test scores. Both cases experienced improvements that surpassed the established 
MDC for late-stage HD for gait speed and Timed Up and Go, while Case 1 also had 
improvements on the Berg Balance Scale and Physical Performance Test that surpassed the 
MDC. * Indicates that improvements in performance met or exceeded established MDC values 
for late-stage HD. 
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Figure 3. A. The individual in Case 1 experienced a marked improvement on the 6-minute walk 
test that far exceeded the established MDC for late-stage HD, while the individual in Case 2 
experienced improvements in B. Four Square Step Test performance, and C. physical quality of 
life as measured by the SF-36 Physical Function Subscale. * Indicates that improvements in 
performance met or exceeded established MDC values for late-stage HD. 
 
